Leamon Christopher P

Vice President of Research at ENDOCYTE INC

Sold, on record
$1.1M
Dollars the filings state
Form 4 sales
8
Latest Oct 5, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ENDOCYTE INCUnusual
    Aug 16, 2012 2012

    Sold 10,000 shares at $9.65 ($97k)

    Leamon Christopher P, Vice President of Research

    Sold 39.9% of holdings ($242k position)15,073 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ENDOCYTE INCUnusual
    May 14, 2013 +271 days

    Sold 5,000 shares at $14.70 ($74k)

    Leamon Christopher P, Vice President of Research

    Sold 33.2% of holdings ($222k position)10,073 shares leftFiling

  3. 3 Form 4 sale ENDOCYTE INCUnusual
    Dec 30, 2016 +1326 days

    Sold 23,244 shares at $2.55 ($59k)

    Leamon Christopher P, Vice President of Research

    Sold 25.8% of holdings ($230k position)66,983 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale ENDOCYTE INCPlan not stated
    Dec 1, 2017 +336 days

    Sold 23,231 shares at $5.03 ($117k)

    Leamon Christopher P, Vice President of Research

    Sold 15.4% of holdings ($758k position)127,348 shares leftFiling

  5. 5 Form 4 sale ENDOCYTE INCPlan not stated
    Mar 9, 2018 +98 days

    Sold 5,036 shares at $9.07 ($46k)

    Leamon Christopher P, Vice President of Research

    Sold 3.4% of holdings ($1.3M position)143,470 shares leftFiling

  6. 6 Form 4 sale ENDOCYTE INCPlan not stated
    Jun 12, 2018 +95 days

    Sold 13,089 shares at $15.06 ($197k)

    Leamon Christopher P, Vice President of Research

    Sold 9.1% of holdings ($2.2M position)130,381 shares left0.6x usual sizeFiling

  7. 7 Form 4 sale ENDOCYTE INCPlan not stated
    Aug 29, 2018 +78 days

    Sold 17,366 shares at $20.00 ($347k)

    Leamon Christopher P, Vice President of Research

    Sold 11.8% of holdings ($3M position)130,381 shares left1x usual sizeFiling

  8. 8 Form 4 sale ENDOCYTE INCPlan not stated
    Oct 5, 2018 +37 days

    Sold 9,028 shares at $15.56 ($140k)

    Leamon Christopher P, Vice President of Research

    Sold 6.9% of holdings ($2M position)121,353 shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Leamon Christopher P
Source
Oct 5, 2018Oct 9, 2018ENDOCYTE INCVice President of ResearchForm 4 sale9,028$140k6.9%Plan not statedSEC
Aug 29, 2018Aug 29, 2018ENDOCYTE INCVice President of ResearchForm 4 sale17,366$347k11.8%Plan not statedSEC
Jun 12, 2018Jun 13, 2018ENDOCYTE INCVice President of ResearchForm 4 sale13,089$197k9.1%Plan not statedSEC
Mar 9, 2018Mar 12, 2018ENDOCYTE INCVice President of ResearchForm 4 sale5,036$46k3.4%Plan not statedSEC
Dec 1, 2017Dec 4, 2017ENDOCYTE INCVice President of ResearchForm 4 sale23,231$117k15.4%Plan not statedSEC
Dec 30, 2016Jan 4, 2017ENDOCYTE INCVice President of ResearchForm 4 sale23,244$59k25.8%UnusualSEC
May 14, 2013May 16, 2013ENDOCYTE INCVice President of ResearchForm 4 sale5,000$74k33.2%UnusualSEC
Aug 16, 2012Aug 17, 2012ENDOCYTE INCVice President of ResearchForm 4 sale10,000$97k39.9%UnusualSEC